Establishing a robust radioligand therapy program: A practical approach for North American centers.
Autorzy:
MittraES; Department of Diagnostic Radiology, Oregon Health & Science University, Portland, Oregon, USA. Wong RKS; Department of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada. Winters C; Department of Diagnostic Radiology, Oregon Health & Science University, Portland, Oregon, USA. Brown A; Department of Diagnostic Radiology, Oregon Health & Science University, Portland, Oregon, USA. Murley S; Department of Nuclear Medicine, West Tennessee Healthcare, Jackson, Tennessee, USA. Kennecke H; Providence Cancer Institute, Portland, Oregon, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (3), pp. e6780. Date of Electronic Publication: 2024 Jan 12.
Initial evaluation of (4S)-4-(3-[ F]fluoropropyl)-L-glutamate (FSPG) PET/CT imaging in patients with head and neck cancer, colorectal cancer, or non-Hodgkin lymphoma.
Autorzy:
Park SY; Department of Radiology, Division of Nuclear Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Molecular Imaging Program at Stanford (MIPS), Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA. Mosci C; Molecular Imaging Program at Stanford (MIPS), Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA. Kumar M; Molecular Imaging Program at Stanford (MIPS), Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA. Wardak M; Molecular Imaging Program at Stanford (MIPS), Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA. Koglin N; Bayer Pharma AG, Berlin, Germany.; Life Molecular Imaging GmbH, Berlin, Germany. Bullich S; Life Molecular Imaging GmbH, Berlin, Germany. Mueller A; Bayer Pharma AG, Berlin, Germany.; Life Molecular Imaging GmbH, Berlin, Germany. Berndt M; Bayer Pharma AG, Berlin, Germany.; Life Molecular Imaging GmbH, Berlin, Germany. Stephens AW; Bayer Pharma AG, Berlin, Germany.; Life Molecular Imaging GmbH, Berlin, Germany. Chin FT; Molecular Imaging Program at Stanford (MIPS), Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA. Gambhir SS; Molecular Imaging Program at Stanford (MIPS), Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA.; Department of Bioengineering, Stanford University, Stanford, CA, USA.; Department of Materials Science & Engineering, Stanford University, Stanford, CA, USA.; Bio-X Program, Stanford University, Stanford, CA, USA. MittraES; Molecular Imaging Program at Stanford (MIPS), Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA. mittra@ohsu.edu.; Department of Diagnostic Radiology, Division of Nuclear Medicine & Molecular Imaging, Oregon Health & Science University, 3181 SW Sam Jackson Park Rd., Mail Code L340, Portland, OR, 97239, USA. mittra@ohsu.edu.
Pokaż więcej
Źródło:
EJNMMI research [EJNMMI Res] 2020 Aug 28; Vol. 10 (1), pp. 100. Date of Electronic Publication: 2020 Aug 28.
Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies.
Autorzy:
MittraES; Molecular Imaging Program, Department of Radiology, Stanford Hospital and Clinics, Stanford, CA, United States of America. Koglin N; Bayer Pharma AG, Berlin, Germany. Mosci C; Molecular Imaging Program, Department of Radiology, Stanford Hospital and Clinics, Stanford, CA, United States of America. Kumar M; Molecular Imaging Program, Department of Radiology, Stanford Hospital and Clinics, Stanford, CA, United States of America. Hoehne A; Molecular Imaging Program, Department of Radiology, Stanford Hospital and Clinics, Stanford, CA, United States of America. Keu KV; Molecular Imaging Program, Department of Radiology, Stanford Hospital and Clinics, Stanford, CA, United States of America. Iagaru AH; Molecular Imaging Program, Department of Radiology, Stanford Hospital and Clinics, Stanford, CA, United States of America. Mueller A; Bayer Pharma AG, Berlin, Germany. Berndt M; Bayer Pharma AG, Berlin, Germany. Bullich S; Piramal Imaging GmbH, Berlin, Germany. Friebe M; Bayer Pharma AG, Berlin, Germany. Schmitt-Willich H; Bayer Pharma AG, Berlin, Germany. Gekeler V; Bayer Pharma AG, Berlin, Germany. Fels LM; Bayer Pharma AG, Berlin, Germany. Bacher-Stier C; Bayer Pharma AG, Berlin, Germany. Moon DH; Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Chin FT; Molecular Imaging Program, Department of Radiology, Stanford Hospital and Clinics, Stanford, CA, United States of America. Stephens AW; Bayer Pharma AG, Berlin, Germany. Dinkelborg LM; Bayer Pharma AG, Berlin, Germany. Gambhir SS; Molecular Imaging Program, Department of Radiology, Stanford Hospital and Clinics, Stanford, CA, United States of America.; Bio-X Program, Department of Bioengineering, Department of Materials Science & Engineering, Stanford University, Stanford, CA, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2016 Feb 18; Vol. 11 (2), pp. e0148628. Date of Electronic Publication: 2016 Feb 18 (Print Publication: 2016).
A single-institution retrospective analysis of outcomes for stage I-II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapy.
Autorzy:
Binkley MS; a Department of Radiation Oncology , Stanford University School of Medicine , Stanford , CA , USA. Hiniker SM; a Department of Radiation Oncology , Stanford University School of Medicine , Stanford , CA , USA. Wu S; b Department of Pathology , Stanford University School of Medicine , Stanford , CA , USA. Natkunam Y; b Department of Pathology , Stanford University School of Medicine , Stanford , CA , USA. MittraES; c Department of Radiology , Stanford University School of Medicine , Stanford , CA , USA. Advani RH; d Department of Medicine , Division of Medical Oncology, Stanford University School of Medicine , Stanford , CA , USA. Hoppe RT; a Department of Radiation Oncology , Stanford University School of Medicine , Stanford , CA , USA.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2016; Vol. 57 (3), pp. 604-8. Date of Electronic Publication: 2015 Aug 28.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
